Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Calcium/calmodulin-dependent protein kinase type IV [15-340] (Homo sapiens (Human)) | BDBM223209 (8-((6-Chloropyrimidin-4-yl)oxy)quinoline (Compound...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | Article PubMed | 0.0109 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
B.R. Ambedkar Bihar University | Assay Description The docking and scoring of ligands with CAMKIV protein was accomplished using ParDOCK module of Sanjeevini drug design suite, which is based on physi... | Chem Biol Drug Des 89: 741-754 (2017) Article DOI: 10.1111/cbdd.12898 BindingDB Entry DOI: 10.7270/Q28C9V30 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium/calmodulin-dependent protein kinase type IV (Homo sapiens (Human)) | BDBM50341519 ((S)-3-(4-(2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vertex Pharmaceuticals (Europe) Ltd. Curated by ChEMBL | Assay Description Inhibition of CAMK4 | J Med Chem 54: 2341-50 (2011) Article DOI: 10.1021/jm101499u BindingDB Entry DOI: 10.7270/Q2KH0NPW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium/calmodulin-dependent protein kinase type IV [15-340] (Homo sapiens (Human)) | BDBM223208 (7-((6-((5-Methoxy-1H-benzo[d]imidazol-2-yl)thio)py...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | 1.35E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
B.R. Ambedkar Bihar University | Assay Description The docking and scoring of ligands with CAMKIV protein was accomplished using ParDOCK module of Sanjeevini drug design suite, which is based on physi... | Chem Biol Drug Des 89: 741-754 (2017) Article DOI: 10.1111/cbdd.12898 BindingDB Entry DOI: 10.7270/Q28C9V30 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium/calmodulin-dependent protein kinase type IV [15-340] (Homo sapiens (Human)) | BDBM223207 (4-Methyl-7-((6-(quinolin-8-yloxy)pyrimidin-4-yl)ox...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | 1.45E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
B.R. Ambedkar Bihar University | Assay Description The docking and scoring of ligands with CAMKIV protein was accomplished using ParDOCK module of Sanjeevini drug design suite, which is based on physi... | Chem Biol Drug Des 89: 741-754 (2017) Article DOI: 10.1111/cbdd.12898 BindingDB Entry DOI: 10.7270/Q28C9V30 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium/calmodulin-dependent protein kinase type IV (Homo sapiens (Human)) | BDBM50463483 (CHEMBL4245242) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid PDB UniChem | Article PubMed | >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vertex Pharmaceuticals Inc Curated by ChEMBL | Assay Description Inhibition of CamK4 (unknown origin) | Bioorg Med Chem Lett 28: 2622-2626 (2018) Article DOI: 10.1016/j.bmcl.2018.06.040 BindingDB Entry DOI: 10.7270/Q2ZC85HX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium/calmodulin-dependent protein kinase type IV (Homo sapiens (Human)) | BDBM50463479 (CHEMBL4249925) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid PDB UniChem | Article PubMed | >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vertex Pharmaceuticals Inc Curated by ChEMBL | Assay Description Inhibition of CamK4 (unknown origin) | Bioorg Med Chem Lett 28: 2622-2626 (2018) Article DOI: 10.1016/j.bmcl.2018.06.040 BindingDB Entry DOI: 10.7270/Q2ZC85HX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium/calmodulin-dependent protein kinase type IV [15-340] (Homo sapiens (Human)) | BDBM223206 (7-[(6-Chloropyrimidin-4-yl)oxy]-4-methyl-2H-chrome...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | 3.57E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
B.R. Ambedkar Bihar University | Assay Description The docking and scoring of ligands with CAMKIV protein was accomplished using ParDOCK module of Sanjeevini drug design suite, which is based on physi... | Chem Biol Drug Des 89: 741-754 (2017) Article DOI: 10.1111/cbdd.12898 BindingDB Entry DOI: 10.7270/Q28C9V30 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium/calmodulin-dependent protein kinase type IV (Homo sapiens (Human)) | BDBM50402020 (CHEMBL2205426) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | >8.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories Curated by ChEMBL | Assay Description Inhibition of recombinant CAMK4 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP | Bioorg Med Chem Lett 22: 7615-22 (2012) Article DOI: 10.1016/j.bmcl.2012.10.009 BindingDB Entry DOI: 10.7270/Q2XK8GQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium/calmodulin-dependent protein kinase type IV (Homo sapiens (Human)) | BDBM50224883 (7-chloro-3-oxo-8-[(thiazol-5-ylmethyl)-amino]-11,1...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | >8.57E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories Curated by ChEMBL | Assay Description Inhibition of CAMK4 | Bioorg Med Chem Lett 17: 6593-601 (2007) Article DOI: 10.1016/j.bmcl.2007.09.063 BindingDB Entry DOI: 10.7270/Q2X067WT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium/calmodulin-dependent protein kinase type IV [15-340] (Homo sapiens (Human)) | BDBM223205 (6-((5-Methoxy-1H-benzo[d]imidazol-2-yl)thio)-N-(4-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | 1.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
B.R. Ambedkar Bihar University | Assay Description The docking and scoring of ligands with CAMKIV protein was accomplished using ParDOCK module of Sanjeevini drug design suite, which is based on physi... | Chem Biol Drug Des 89: 741-754 (2017) Article DOI: 10.1111/cbdd.12898 BindingDB Entry DOI: 10.7270/Q28C9V30 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium/calmodulin-dependent protein kinase type IV [15-340] (Homo sapiens (Human)) | BDBM223204 (8-((6-((5-Methoxy-1H-benzo[d]imidazol-2-yl)thio)py...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | 2.44E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
B.R. Ambedkar Bihar University | Assay Description The docking and scoring of ligands with CAMKIV protein was accomplished using ParDOCK module of Sanjeevini drug design suite, which is based on physi... | Chem Biol Drug Des 89: 741-754 (2017) Article DOI: 10.1111/cbdd.12898 BindingDB Entry DOI: 10.7270/Q28C9V30 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Calcium/calmodulin-dependent protein kinase type IV [15-340] (Homo sapiens (Human)) | BDBM223203 (8-((6-(Naphthalen-2-yloxy)pyrimidin-4-yl)oxy)quino...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | 6.67E+5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
B.R. Ambedkar Bihar University | Assay Description The docking and scoring of ligands with CAMKIV protein was accomplished using ParDOCK module of Sanjeevini drug design suite, which is based on physi... | Chem Biol Drug Des 89: 741-754 (2017) Article DOI: 10.1111/cbdd.12898 BindingDB Entry DOI: 10.7270/Q28C9V30 | |||||||||||
More data for this Ligand-Target Pair |